Search

Search Constraints

You searched for: Author/Creator San Martin, Javier

Search Results

1. A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults With X‐Linked Hypophosphatemia: Week 24 Primary Analysis. (26th June 2018)

3. Burosumab for the Treatment of Tumor‐Induced Osteomalacia. (12th January 2021)

4. Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial. (1st October 2019)

5. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Issue 10189 (15th June 2019)